Correction: An inhibitor of the pleckstrin homology domain of CNK1 selectively blocks the growth of mutant KRAS cells and tumors (Cancer Research (2019) 79 (3100–3111) DOI: 10.1158/0008-5472.CAN-18-2372)

Martin Indarte, Roisin Puentes, Marco Maruggi, Nathan T. Ihle, Geoffrey Grandjean, Michael Scott, Zamal Ahmed, Emmanuelle J. Meuillet, Shuxing Zhang, Robert Lemos, Lei Du-Cuny, Fabiana I.A.L. Layng, Ricardo G. Correa, Laurie A. Bankston, Robert C. Liddington, Lynn Kirkpatrick, Garth Powis

Research output: Contribution to journalComment/debate

Abstract

In the original version of this article (1), the name of the ninth author, Shuxing Zhang, is incorrect. The name has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Original languageEnglish (US)
Number of pages1
JournalCancer Research
Volume79
Issue number20
DOIs
StatePublished - Oct 15 2019

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Indarte, M., Puentes, R., Maruggi, M., Ihle, N. T., Grandjean, G., Scott, M., Ahmed, Z., Meuillet, E. J., Zhang, S., Lemos, R., Du-Cuny, L., Layng, F. I. A. L., Correa, R. G., Bankston, L. A., Liddington, R. C., Kirkpatrick, L., & Powis, G. (2019). Correction: An inhibitor of the pleckstrin homology domain of CNK1 selectively blocks the growth of mutant KRAS cells and tumors (Cancer Research (2019) 79 (3100–3111) DOI: 10.1158/0008-5472.CAN-18-2372). Cancer Research, 79(20). https://doi.org/10.1158/0008-5472.CAN-19-2586